APT(SH:688617) Xin Lang Zheng Quan·2025-09-11 12:56Core Viewpoint - Shenzhen Huitai Medical Devices Co., Ltd. announced the share reduction of its major shareholder, Vice Chairman and General Manager Cheng Zhenghui, due to personal funding needs [1][3]. Shareholding Situation Before Reduction - Before the reduction, Cheng Zhenghui held 26,371,507 shares, accounting for 18.70% of the total share capital. His shares were acquired through various means, including 12,511,911 shares before the IPO and 41,628 shares from equity incentives [2]. - Cheng Zhenghui and Wen Yiming are acting in concert, with Wen holding 19,765 shares (0.01%), bringing their combined holdings to 26,391,272 shares (18.72%) [2]. Reduction Plan and Implementation Results - On August 13, 2025, the company disclosed that Cheng Zhenghui planned to reduce his holdings by up to 2% of the total share capital, equivalent to 2,820,275 shares, through block trading [3]. - From September 3 to September 11, 2025, Cheng Zhenghui successfully reduced his holdings by 2,820,275 shares at a price range of 248.20 CNY per share, completing the reduction plan [3]. Changes in Equity - Following the reduction, Cheng Zhenghui's shareholding decreased to 23,551,232 shares, representing 16.70% of the total share capital, a decrease of 2% [4]. - Wen Yiming's shareholding remained unchanged at 19,765 shares (0.01%), resulting in a combined holding of 23,570,997 shares (16.72%) [4]. - This reduction does not affect the company's controlling shareholder or actual controller, nor does it significantly impact the company's governance structure or ongoing operations [4].